P2X3, receptor antagonists for treatment of pain

Details for Australian Patent Application No. 2009309019 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Burgey, Christopher S.; Deng, Zhengwu J.; Nguyen, Diem N.; Paone, Daniel V.; Shaw, Anthony W.

Agent Spruson & Ferguson

Pub. Number AU-A-2009309019

PCT Pub. Number WO2010/051188

Priority 61/227,285 21.07.09 US; 61/197,869 31.10.08 US

Filing date 21 October 2009

Wipo publication date 6 May 2010

International Classifications

C07D 239/02 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/051188 Priority application(s): WO2010/051188

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009309025-Oval burner alignment method

2009309008-Triazole beta carboline derivatives as antidiabetic compounds